The Accuracy and Acceptability of Magnet Assisted Capsule Endoscopy in the Diagnosis of Esophageal Pathology: a Pilot Study

Oesophageal Varices Clinical Trial

— MACE  

Official title:

The Accuracy and Acceptability of Magnet Assisted Capsule Endoscopy in the Diagnosis of Esophageal Pathology: a Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02852161
• Other study ID #: 15109
• Status: Completed
• Phase: N/A
• Start date: July 2016
• Est. completion date: October 2018

Study information

• Verified date: January 2022
• Source: University of Nottingham
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A pilot study to assess the accuracy and acceptability of a magnet assisted capsule endoscopy in detecting esophageal pathology compared to standard endoscopy.

Description:

This will be a single centre feasibility study performed at Nottingham University Hospitals NHS Trusts.

We will assess the accuracy of MACE compared to gastroscopy in diagnosing Barretts oesophagus and esophageal varices. Patients will have both tests on the same ay, with the endoscopic findings compared.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: October 2018
• Est. primary completion date: October 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Due to have a clinically indicated gastroscopy Barrett's oesophagus/ oesophageal varices or Controls Able to give informed consent

Exclusion Criteria:

Unable to give consent Pregnant Pacemaker swallowing difficulties

Related Conditions & MeSH terms

• Barrett Esophagus
• Barrett's Oesophagus
• Oesophageal Varices

Intervention

Device:
• Magnet assissted capsule endoscopy
Patients due to have a clinically indicated gastroscopy will be asked to have a MACE procedure on the same day

Locations

Country	Name	City	State
United Kingdom	Nottingham University Hospital	Nottingham

Sponsors (1)

Lead Sponsor	Collaborator
University of Nottingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Diagnostic accuarcy	endoscopic	immediate
Secondary	comfort	questionnaire	2 weeks